Methods of using (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acidCPPTue, October 24th - 5:48 AM 2017
METHODS OF USING (1S, 3S) -3-AMINO-4-DIFLUOROMETHYLENYL-1-CYCLOPENTANOIC ACIDCPPWed, November 22nd - 8:57 AM 2017
FORM 8-K: Adamas Pharmaceuticals Inc FILES Current reportCompetitive IntelligenceTue, January 23rd - 12:00 AM 2018
Auris Medical Holding Ag Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16]: (Jan. 16, 2018)Competitive IntelligenceMon, January 29th - 12:00 AM 2018
Auris Medical Announces Pricing of $5.5 Million Registered Direct OfferingCompetitive IntelligenceMon, January 29th - 12:00 AM 2018
Auris Medical 12.5M share registered direct offering priced at $0.44Competitive IntelligenceMon, January 29th - 12:00 AM 2018
Alkermes falls in 4 out of last 5 days January 31, 2018 16:00 ESTCompetitive IntelligenceWed, January 31st - 12:00 AM 2018
More Results...Competitive IntelligenceWed, February 14th - 1:09 PM 2018
USE (1S,3S)-3-AMINO-4-DIFLUOROMETHYLENYL-1-CYCLOPENTANOIC ACID AS A GABA AMINOTRANSFERSE INHIBITORCPPThu, June 21st - 7:22 AM 2018
VERFAHREN ZUR VERWENDUNG VON (1S,3S-)-3-AMINO-4-DIFLUORMETHYLENYL-1-CYCLOPENTAN-SÄURECPPMon, August 12th - 6:15 AM 2019

Pages